Not Yet Recruiting
IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer
NCT07402070
- Conditions
- Resectable Stage II-III Non-small Cell Lung Cancer
- Locations
-
- Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China